Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
NANOBAC PHARM (NNBP) had Days Sales in Receivables of -60.00 for the most recently reported fiscal quarter, ending 2007-12-31.
| Income Statement Financials | |
$-0.00M |
|
$-1.18M |
|
-- |
|
$-0.00M |
|
$1.17M |
|
$-1.17M |
|
$-0.04M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.17M |
|
$-1.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.03M |
|
$0.16M |
|
$7.31M |
|
$7.22M |
|
$6.74M |
|
-- |
|
$2.83M |
|
$9.58M |
|
$-2.36M |
|
$-9.50M |
|
$-2.36M |
|
-- |
|
| Cash Flow Statement Financials | |
$-0.91M |
|
$0.04M |
|
$0.91M |
|
$0.04M |
|
$0.00M |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-1.75 |
|
-- |
|
39100.00% |
|
39100.00% |
|
-- |
|
39333.33% |
|
39333.33% |
|
$-0.91M |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-1.50 |
|
|
Days Sales in Receivables |
-60.00 |
50.00% |
|
12.42% |
|
-16.34% |
|
50.00% |
|
-- |
|
-- |
|
-- |
|